Project Grant R21AI199526
Award Date 6/2/26
Completion Date 5/31/28
Dollars Obligated $235K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
- Federal Project Grant Award Summary Emory University received a $1.17 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 16, 2025, with completion targeted for August 31, 2030. This research project, conducted at Emory's Atlanta location, focuses on characterizing the infectiousness and social mixing patterns associated with asymptomatic tuberculosis (TB) as a...
- Federal Project Grant Summary Emory University received a $821,087 Project Grant awarded August 8, 2025, by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct a five-year research study examining the relationship between latent tuberculosis infection (LTBI) and cardiometabolic disease risk. The research will generate scientific evidence establishing whether LTBI increases the risk of diabetes...
- Federal Project Grant Award Summary Emory University's Office of Sponsored Programs received a $430,375 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, with completion scheduled for July 31, 2027. The award funds investigator-initiated biomedical research examining inter-membrane lipid signaling mechanisms in gram-negative bacteria, specifically focusing on...
- Federal Grant Award Summary Emory University received a $161,244 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on April 16, 2026, with a completion date of March 31, 2028. This research initiative addresses the critical public health challenge of multidrug-resistant bacterial pathogens, particularly the ESKAPE group (Enterococcus faecium, Staphylococcus aureus, Klebsiella...
- Federal Grant Award Summary Emory University received a $160,546.00 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 3, 2025, through August 31, 2029. The project, titled "Towards Foundation Epidemic Models for Respiratory Infections: A Novel Spatiotemporal Machine Learning Framework," will be conducted at Emory's Atlanta, Georgia campus. This award...
- Federal Grant Award Summary Emory University received a $2,297,892 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 17, 2025, with completion targeted for June 30, 2029. The award funds a four-year research investigation into the mechanisms by which interferon-induced transmembrane proteins (IFITMs) inhibit viral membrane fusion and restrict diverse enveloped viruses...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Emory University $192,027.00 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on August 4, 2025, for a project period extending through July 31, 2030. This K24 award supports Dr. Russell Kempker's research program titled "Enhancing Research and Mentoring Skills in Tuberculosis (EARN TB)," which focuses on advancing tuberculosis (TB) patient-oriented research and...
- Federal Grant Award Summary Emory University received a $909,998 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 5, 2026, with completion targeted for January 31, 2031. The research focuses on developing an antiretroviral therapy (ART)-free approach to establishing and managing simian immunodeficiency virus (SIV) reservoirs through antibody-mediated intervention. The...
- Federal Grant Award Summary Emory University received a $100,228 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) for research conducted in Atlanta, Georgia. The award, issued September 30, 2026, with a completion date of September 29, 2028, supports investigator-initiated biomedical research examining the regulatory mechanisms controlling sporulation, motility, and virulence in...
- Federal Project Grant Award Summary The University of Alabama at Birmingham received a $742,499 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 12, 2025, with completion targeted for July 31, 2030. This award funds molecular investigation research focused on understanding siderophore secretion and drug efflux mechanisms in Mycobacterium tuberculosis (M. tuberculosis). The...